The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 2, 2025

December 2, 2025

NRx Pharmaceuticals (NASDAQ: NRXP) and HOPE Therapeutics to Host Corporate Update Call

GlobeNewswire

December 2, 2025

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025

GlobeNewswire

December 2, 2025

CervoMed Presents New Plasma Biomarker Data That Indicates Neflamapimod Broadly Improves Neuroinflammation and Neurodegeneration in Dementia with Lewy Bodies (DLB)

GlobeNewswire

December 2, 2025

Pasithea Therapeutics Announces Closing of $60 Million Public Offering of Common Stock

GlobeNewswire

December 2, 2025

Fractyl Health Reports Positive 6-Month REVEAL-1 Open-Label Results Showing Sustained Post-GLP-1 Weight Maintenance After a Single Revita® Procedure

GlobeNewswire

December 2, 2025

Jasper Therapeutics Reports Positive Preliminary Data from ETESIAN Study of Briquilimab in Asthma and Findings from BEACON Study Internal Investigation

GlobeNewswire

December 2, 2025

Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer

GlobeNewswire

December 2, 2025

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company

GlobeNewswire

December 2, 2025

Hydreight Technologies Announces Corporate Update Highlighting Q3 Momentum, VSDHOne Acceleration, and 2026 Outlook

GlobeNewswire

December 2, 2025

ANI Pharmaceuticals Announces Formation of “FutureVision Advisory Council” to Help Strategically Guide Ophthalmology and Retina Franchise

GlobeNewswire

December 2, 2025

Alberta Cancer Foundation launches 'The Time Store' campaign to bring more moments to Albertans facing cancer

GlobeNewswire

December 2, 2025

The Ensign Group Increases Operations in Arizona

GlobeNewswire

December 2, 2025

The Ensign Group Adds Real Estate and Operations in Kansas

GlobeNewswire

December 2, 2025

The Ensign Group Grows Operations in Colorado

GlobeNewswire

December 2, 2025

tiakis Biotech Successfully Completes Data Package to Advance Tiprelestat into Phase II clinical trial in PAH

GlobeNewswire

December 2, 2025

Rentschler Biopharma and Coriolis Pharma announce strategic collaboration for integrated biopharma solutions

GlobeNewswire

December 2, 2025

Tacalyx Appoints Jean Engela as Chief Executive Officer to Spearhead Next Phase of Growth

GlobeNewswire

December 2, 2025

Vandria Reports Positive Phase 1 Target Engagement Data for VNA-318, Supporting Further Development in Alzheimer’s Disease

GlobeNewswire

December 2, 2025

Enterome OncoMimics™ immunotherapy EO2401 shows survival benefit in Phase 2 glioblastoma trial

GlobeNewswire

December 2, 2025

Kuros Biosciences announces enrollment of first patient in ASTRA study – A global, prospective, randomized, multi-center clinical trial in foot and ankle fusion

GlobeNewswire